Archives for: February 26th, 2018

CorMedix Inc. Granted Orphan Drug Designation for Taurolidine for Treatment of Neuroblastoma

Written by Sam Nelson on February 26, 2018

Berkeley Heights, NJ – February 26, 2018 – CorMedix Inc. (NYSE…

CorMedix Inc. Achieves Target Number of Events in Its LOCK-IT-100 Study of Neutrolin® for Interim Efficacy Analysis

Written by Sam Nelson on February 20, 2018

Berkeley Heights, NJ – February 20, 2018 – CorMedix Inc. (NYSE…